---
schema_version: "secwatch.filing_event.v1"
accession: "0001819790-26-000048"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2026-07-13T20:11:59+00:00"
generated_at: "2026-07-13T20:13:05.001250+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Tarsus CCO Aziz Mottiwala departing July 15 to become CEO of another public med device company

## Summary
- Aziz Mottiwala to leave role as Chief Commercial Officer and employment on July 15, 2026.
- Mottiwala is departing to become CEO of a public medical device company.
- No successor or interim CCO has been announced by Tarsus Pharmaceuticals.
- Announcement made on July 13, 2026; departure is voluntary for an external CEO opportunity.

## SEC filing metadata
- accession: 0001819790-26-000048
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2026-07-13T20:11:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000181979026000048/0001819790-26-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000181979026000048/tars-20260713.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001819790-26-000048
- JSON: https://secwatch.observer/filing/0001819790-26-000048.json
- Plain text: https://secwatch.observer/filing/0001819790-26-000048.txt

## Key facts
- Executive change
  Aziz Mottiwala resigned as Chief Commercial Officer at Tarsus Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Chief Commercial Officer
  source text: On July 13, 2026, Tarsus Pharmaceuticals, Inc. (the “Company”) announced that Aziz Mottiwala would be leaving his role as the Company’s Chief Commercial Officer and leaving his employment with the Company on July 15, 2026, to pursue a new opportunity as Chief Executive Officer of a public medical device company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819790/000181979026000048/0001819790-26-000048-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.